TY - JOUR
T1 - Dosage, intensity, and frequency of language therapy for aphasia: a systematic review–based, individual participant data network meta-analysis
AU - Brady, Marian C.
AU - Ali, Myzoon
AU - VandenBerg, Kathryn
AU - Williams, Linda J.
AU - Williams, Louise R.
AU - Abo, Masahiro
AU - Becker, Frank
AU - Bowen, Audrey
AU - Brandenburg, Caitlin
AU - Breitenstein, Caterina
AU - Bruehl, Stefanie
AU - Copland, David A.
AU - Cranfill, Tamara B.
AU - di Pietro-Bachmann, Marie
AU - Enderby, Pamela
AU - Fillingham, Joanne
AU - Galli, Federica Lucia
AU - Gandolfi, Marialuisa
AU - Glize, Bertrand
AU - Godecke, Erin
AU - Hawkins, Neil
AU - Hilari, Katerina
AU - Hinckley, Jacqueline
AU - Horton, Simon
AU - Howard, David
AU - Jaecks, Petra
AU - Jefferies, Elizabeth
AU - Jesus, Luis M.T.
AU - Kambanaros, Maria
AU - Kyoung Kang, Eun
AU - Khedr, Eman M.
AU - Pak-Hin Kong, Anthony
AU - Kukkonen, Tarja
AU - Laganaro, Marina
AU - Lambon Ralph, Matthew A.
AU - Laska, Ann Charlotte
AU - Leemann, Béatrice
AU - Leff, Alexander P.
AU - Lima, Roxele R.
AU - Lorenz, Antje
AU - MacWhinney, Brian
AU - Shisler Marshall, Rebecca
AU - Mattioli, Flavia
AU - Maviş, İlknur
AU - Meinzer, Marcus
AU - Nilipour, Reza
AU - Noé, Enrique
AU - Paik, Nam-Jong
AU - Palmer, Rebecca
AU - Papathanasiou, Ilias
AU - Patricio, Brigida
AU - Pavão Martins, Isabel
AU - Price, Cathy
AU - Prizl Jakovac, Tatjana
AU - Rochon, Elizabeth
AU - Rose, Miranda L.
AU - Rosso, Charlotte
AU - Rubi-Fessen, Ilona
AU - Ruiter, Marina B.
AU - Snell, Claerwen
AU - Stahl, Benjamin
AU - Szaflarski, Jerzy P.
AU - Thomas, Shirley A.
AU - van de Sandt-Koenderman, Mieke
AU - van der Meulen, Ineke
AU - Visch-Brink, Evy
AU - Worrall, Linda
AU - Harris Wright, Heather
AU - The RELEASE Collaborators
PY - 2022/3
Y1 - 2022/3
N2 - Background and Purpose:Optimizing speech and language therapy (SLT) regimens for maximal aphasia recovery is a clinical research priority. We examined associations between SLT intensity (hours/week), dosage (total hours), frequency (days/week), duration (weeks), delivery (face to face, computer supported, individual tailoring, and home practice), content, and language outcomes for people with aphasia.Methods:Databases including MEDLINE and Embase were searched (inception to September 2015). Published, unpublished, and emerging trials including SLT and ≥10 individual participant data on aphasia, language outcomes, and time post-onset were selected. Patient-level data on stroke, language, SLT, and trial risk of bias were independently extracted. Outcome measurement scores were standardized. A statistical inferencing, one-stage, random effects, network meta-analysis approach filtered individual participant data into an optimal model examining SLT regimen for overall language, auditory comprehension, naming, and functional communication pre-post intervention gains, adjusting for a priori–defined covariates (age, sex, time poststroke, and baseline aphasia severity), reporting estimates of mean change scores (95% CI).Results:Data from 959 individual participant data (25 trials) were included. Greatest gains in overall language and comprehension were associated with >20 to 50 hours SLT dosage (18.37 [10.58–26.16] Western Aphasia Battery–Aphasia Quotient; 5.23 [1.51–8.95] Aachen Aphasia Test–Token Test). Greatest clinical overall language, functional communication, and comprehension gains were associated with 2 to 4 and 9+ SLT hours/week. Greatest clinical gains were associated with frequent SLT for overall language, functional communication (3–5+ days/week), and comprehension (4–5 days/week). Evidence of comprehension gains was absent for SLT ≤20 hours, <3 hours/week, and ≤3 days/week. Mixed receptive-expressive therapy, functionally tailored, with prescribed home practice was associated with the greatest overall gains. Relative variance was <30%. Risk of trial bias was low to moderate; low for meta-biases.Conclusions:Greatest language recovery was associated with frequent, functionally tailored, receptive-expressive SLT, with prescribed home practice at a greater intensity and duration than reports of usual clinical services internationally. These exploratory findings suggest critical therapeutic ranges, informing hypothesis-testing trials and tailoring of clinical services.
AB - Background and Purpose:Optimizing speech and language therapy (SLT) regimens for maximal aphasia recovery is a clinical research priority. We examined associations between SLT intensity (hours/week), dosage (total hours), frequency (days/week), duration (weeks), delivery (face to face, computer supported, individual tailoring, and home practice), content, and language outcomes for people with aphasia.Methods:Databases including MEDLINE and Embase were searched (inception to September 2015). Published, unpublished, and emerging trials including SLT and ≥10 individual participant data on aphasia, language outcomes, and time post-onset were selected. Patient-level data on stroke, language, SLT, and trial risk of bias were independently extracted. Outcome measurement scores were standardized. A statistical inferencing, one-stage, random effects, network meta-analysis approach filtered individual participant data into an optimal model examining SLT regimen for overall language, auditory comprehension, naming, and functional communication pre-post intervention gains, adjusting for a priori–defined covariates (age, sex, time poststroke, and baseline aphasia severity), reporting estimates of mean change scores (95% CI).Results:Data from 959 individual participant data (25 trials) were included. Greatest gains in overall language and comprehension were associated with >20 to 50 hours SLT dosage (18.37 [10.58–26.16] Western Aphasia Battery–Aphasia Quotient; 5.23 [1.51–8.95] Aachen Aphasia Test–Token Test). Greatest clinical overall language, functional communication, and comprehension gains were associated with 2 to 4 and 9+ SLT hours/week. Greatest clinical gains were associated with frequent SLT for overall language, functional communication (3–5+ days/week), and comprehension (4–5 days/week). Evidence of comprehension gains was absent for SLT ≤20 hours, <3 hours/week, and ≤3 days/week. Mixed receptive-expressive therapy, functionally tailored, with prescribed home practice was associated with the greatest overall gains. Relative variance was <30%. Risk of trial bias was low to moderate; low for meta-biases.Conclusions:Greatest language recovery was associated with frequent, functionally tailored, receptive-expressive SLT, with prescribed home practice at a greater intensity and duration than reports of usual clinical services internationally. These exploratory findings suggest critical therapeutic ranges, informing hypothesis-testing trials and tailoring of clinical services.
KW - aphasia
KW - big data
KW - comprehension
KW - language therapy
KW - meta-analysis
KW - stroke
KW - stroke/complications
KW - stroke rehabilitation/methods
KW - humans
KW - language therapy/methods
KW - network meta-analysis
KW - aphasia/etiology
U2 - 10.1161/STROKEAHA.121.035216
DO - 10.1161/STROKEAHA.121.035216
M3 - Article
C2 - 34847708
SN - 0039-2499
VL - 53
SP - 956
EP - 967
JO - Stroke
JF - Stroke
IS - 3
ER -